• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Is j hollaway still at vertex?

Quote

Anonymous

Guest
Rumor has it that vertex figured this d-bag out quickly and let him go! Anyone know if this is true? At least they are smarter than Roche, they let him screw around over there for years.
 








I cannot believe he got hired to lead a team when he has no experience in hep c. Good luck to his employees.....Vertex you will be sorry! He has a bad reputation with his past colleagues at Roche/Genentech. You should have done your homework.
 








What?....Race has nothing to do with it. He is just not that bright or talented. He thinks he is smarter than he is, period. Good people skills has nothing to do with race.
 




How is this guy doing? I imagine he has already starting driving people nuts with his bs. Give everyone an update.....I am sure you will have some interesting stories given his past history.....
 












Top Bottom
Back
Quote